0%
Interim Lung Update 2026 - LUNG MATTERS: Translating Treatment To Survival. Academic webinar on 28th July 2026, 07:00 to 09:00 via Zoom.
Interim Lung Update 2026 with theme 'LUNG MATTERS: Translating Treatment To Survival' is a specialized academic webinar held on 28th July 2026 from 07:00 to 09:00 under the aegis of Academy of Cancer Care Foundation and Research Center, Practice Events, and Keyson Healthcare. Scientific agenda includes: 'Role of Tecentriq in Extensive Stage- Small Cell Lung Cancer with the longest OS follow up' by Dr. Venkat Sampath; 'Alesia-7year update: Alectinib vs crizotinib in asian patients with treatment-naive advanced ALK+ NSCLC' by Dr. Shyny Reddy; 'Redefining the treatment options in patients with NSCLC not eligible for platinum therapy' moderated by Dr. Rakesh Pinninti (Panelists: Dr. Sindhu, Dr. Namratha, Dr. Raveena, Dr. Nishith, Dr. Goutham); and 'Case based panel discussion on 1 LNSCLC' moderated by Dr. Vindhya Vasini (Panelists: Dr. Sanath, Dr. Divya, Dr. Pallavi, Dr. Harshavardhan, Dr. Sharath Chandra Goteti). Contact Priya (99884 63222) or Kalyani (90827 08325) for registration.
The primary aim of Interim Lung Update 2026 is to deliver updated, evidence-based scientific insights into lung cancer management, molecular diagnostic algorithms, and novel targeted & immunotherapy regimens in NSCLC & SCLC. The program seeks to foster multidisciplinary collaboration among clinical specialists, enhance diagnostic accuracy, and translate groundbreaking clinical trial data into daily clinical practice.
The program was conducted as a structured virtual webinar & interactive online forum. The scientific agenda comprised keynote lectures by distinguished domain experts, case-based panel discussions on complex clinical scenarios, interactive Q&A sessions, and comprehensive reviews of landmark clinical trials in Thoracic Oncology.
The conference successfully equipped participating healthcare professionals with practical strategies for optimizing clinical decision-making in Thoracic Oncology. By establishing updated treatment algorithms and promoting collaborative care networks, the event reinforces commitment to improving patient survival rates and quality of life.